Advertisement

Topics

FDA expands indication for Eylea to cover all stages of diabetic retinopathy http://bit.ly/2W4SdGd  #pharma #diabetes

14:15 EDT 14 May 2019 | Pharmafile

FDA expands indication for Eylea to cover all stages of diabetic retinopathy http://bit.ly/2W4SdGd 

Original Article: FDA expands indication for Eylea to cover all stages of diabetic retinopathy http://bit.ly/2W4SdGd  #pharma #diabetes

NEXT ARTICLE

More From BioPortfolio on "FDA expands indication for Eylea to cover all stages of diabetic retinopathy http://bit.ly/2W4SdGd  #pharma #diabetes"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...